DIPLOMAT PHARMACY INC's ticker is and the CUSIP is 25456K901. A total of 1 filers reported holding DIPLOMAT PHARMACY INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,398,000 | +34850.0% | 349,500 | +49828.6% | 0.01% | – |
| Q2 2019 | $4,000 | -73.3% | 700 | -73.1% | 0.00% | – |
| Q1 2019 | $15,000 | +650.0% | 2,600 | +2500.0% | 0.00% | – |
| Q1 2018 | $2,000 | -75.0% | 100 | -75.0% | 0.00% | – |
| Q4 2017 | $8,000 | -74.2% | 400 | -73.3% | 0.00% | – |
| Q3 2017 | $31,000 | +47.6% | 1,500 | +7.1% | 0.00% | – |
| Q2 2017 | $21,000 | -97.2% | 1,400 | -93.6% | 0.00% | -100.0% |
| Q2 2016 | $763,000 | +66.6% | 21,800 | +30.5% | 0.01% | +50.0% |
| Q1 2016 | $458,000 | +0.7% | 16,700 | +25.6% | 0.01% | +20.0% |
| Q4 2015 | $455,000 | -45.4% | 13,300 | -54.1% | 0.01% | -58.3% |
| Q3 2015 | $833,000 | +79.1% | 29,000 | +178.8% | 0.01% | +71.4% |
| Q2 2015 | $465,000 | +33.2% | 10,400 | +3.0% | 0.01% | +40.0% |
| Q1 2015 | $349,000 | – | 10,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |